University of Notre Dame du Lac’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-100,229
Closed -$8.12M 79
2017
Q3
$8.12M Sell
100,229
-1,819
-2% -$139K 2.26% 9
2017
Q2
$7.22M Sell
102,048
-23,589
-19% -$1.57M 2.14% 8
2017
Q1
$8.53M Buy
+125,637
New +$8.83M 2.13% 7
2016
Q4
Sell
-27,193
Closed -$2.15M 48
2016
Q3
$2.15M Buy
27,193
+3,384
+14% +$275K 1.86% 28
2016
Q2
$1.99M Buy
23,809
+9,307
+64% +$826K 1.87% 26
2016
Q1
$1.33M Buy
14,502
+4,468
+45% +$403K 1.64% 40
2015
Q4
$1.01M Buy
+10,034
New +$1.04M 0.94% 30

Other funds holding GILD

University of Notre Dame du Lac's GILD Position: Q4 2017 in Review

University of Notre Dame du Lac sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 100,229 shares — an estimated $8.12M sold.

University of Notre Dame du Lac first reported a position in GILD in Q4 2015 and held it in 7 quarters. The position peaked at $8.53M in Q1 2017. 1,575 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • University of Notre Dame du Lac reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • University of Notre Dame du Lac sold 100,229 Gilead Sciences shares in Q4 2017, an estimated $8.12M.
  • University of Notre Dame du Lac first reported a position in Gilead Sciences in Q4 2015 and held it in 7 quarters.
  • University of Notre Dame du Lac's Gilead Sciences position peaked at $8.53M in Q1 2017.
  • 1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on University of Notre Dame du Lac's 13F filing for Q4 2017, filed 13 Feb 2018.